The ketogenic diet has been used as a therapy for refractory epilepsy in children since the 1920's. It was only recently, however, that a randomized, controlled study confirmed it to be effective in reducing seizures. Is there a role for the ketogenic diet as first-line therapy for epilepsy? Which patients stand to benefit the most from this diet, and what are some of its potential adverse effects? Dr. Douglas Nordli, associate professor of neurology and pediatrics at Northwestern University's Feinberg School of Medicine, and the Lorna S. and James P. Langdon Chair of Pediatric Epilepsy, offers details on this trial and explores mechanisms through which we may generate more timely results in our research for patients with epilepsy. Dr. Jennifer Shu hosts.
Ketogenic Diet for Refractory Epilepsy: Beyond Anecdotes

Ready to Claim Your Credits?
You have attempts to pass this post-test. Take your time and review carefully before submitting.
Good luck!
Overview
The ketogenic diet has been used as a therapy for refractory epilepsy in children since the 1920's. It was only recently, however, that a randomized, controlled study confirmed it to be effective in reducing seizures. Is there a role for the ketogenic diet as first-line therapy for epilepsy? Which patients stand to benefit the most from this diet, and what are some of its potential adverse effects? Dr. Douglas Nordli, associate professor of neurology and pediatrics at Northwestern University's Feinberg School of Medicine, and the Lorna S. and James P. Langdon Chair of Pediatric Epilepsy, offers details on this trial and explores mechanisms through which we may generate more timely results in our research for patients with epilepsy. Dr. Jennifer Shu hosts.
Title
Share on ReachMD
CloseProgram Chapters
Segment Chapters
Playlist:
Recommended
Integrating Guideline Directed Medical Therapy for Patients with CKD and T2D
New Horizons: Unraveling Novel Therapies for Enhanced Cardiovascular Outcomes in Patients With Heart Failure
HF Management for Patients with Comorbid Conditions
Level Up Your Skills: Tailoring Management of HF
What do we know now that could have changed the history of CETP inhibition?: genetics and biology
Risk Assessment in Pulmonary Hypertension: Practice Trends and Updates
From Diagnosis to Treatment: Challenges in Glioblastoma Care
Bladders, Breakthroughs, and Bold New Therapies: Key Updates at AUA 2025
We’re glad to see you’re enjoying ReachMD…
but how about a more personalized experience?